Werewolf Therapeutics Inc...

AI Score

0

Unlock

1.14
-0.10 (-8.06%)
At close: Mar 03, 2025, 3:59 PM
1.14
0.57%
After-hours: Mar 03, 2025, 05:01 PM EST

Werewolf Therapeutics Income Statement

Year FY23 FY22 FY21 FY20 FY19
Revenue 19.94M 16.4M n/a n/a n/a
Cost of Revenue 38.91M 2.51M 735K 777K 463K
Gross Profit -18.96M 13.89M -735K -777K -463K
Operating Income -40.5M -56.06M -50.09M -22.4M -9.94M
Interest Income 7.42M 1.91M 104K 101K 372K
Pretax Income -37.37M -53.81M -49.98M -15.04M -10.25M
Net Income -37.37M -51.56M -49.77M -14.94M -10.99M
Selling & General & Admin 18.67M 18.7M 14.82M 5.76M 3.6M
Research & Development 41.78M 53.76M 35.27M 16.64M 6.34M
Other Expenses n/a 2.25M 104K 7.26M 430K
Operating Expenses 60.45M 72.46M 50.09M 22.4M 9.94M
Interest Expense 3.14M n/a n/a n/a 372K
Selling & Marketing Expenses n/a n/a n/a n/a n/a
Cost & Expenses 60.45M 72.46M 50.09M 22.4M 9.94M
Income Tax n/a -2.25M -216K -101K 742K
Shares Outstanding (Basic) 35.65M 28.86M 27.31M 28.66M 28.66M
Shares Outstanding (Diluted) 35.65M 28.86M 27.31M 28.66M 28.66M
EPS (Basic) -1.05 -1.79 -1.82 -0.52 -0.38
EPS (Diluted) -1.05 -1.79 -1.82 -0.52 -0.38
EBITDA -32.47M -51.3M -49.25M -14.26M -9.41M
Depreciation & Amortization 1.76M 2.51M 735K 777K 463K